BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 107611)

  • 1. [Pharmacodynamics of Sustak and Nitrong in patients with angina pectoris].
    Metelitsa VI; Nikolenko SA; Nazarenko VA; Savvateev KL; Vygodin VA
    Ter Arkh; 1979; 51(1):40-9. PubMed ID: 107611
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man.
    Hirshleifer I
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of ethyl cinepazate maleate on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Mercuro G; Lai C
    Boll Soc Ital Cardiol; 1978; 23(1):265-80. PubMed ID: 113021
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperbaric oxygenation and antianginal preparations: the effect of a single combined use on the functional indices of the state of the heart in patients with angina pectoris].
    Seriakov VV; Efuni SN; Sidorenko BA
    Anesteziol Reanimatol; 1992; (2):9-13. PubMed ID: 1416216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
    Volkov VS; Bratoliubov VP
    Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline].
    Volkov VS; Bratoliubov VP
    Sov Med; 1985; (7):77-80. PubMed ID: 3934766
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of controlled-release nitroglycerin tablets (Nitrong) in the treatment of angina pectoris.
    Blinder S
    Curr Ther Res Clin Exp; 1965 Dec; 7(12):769-72. PubMed ID: 4954447
    [No Abstract]   [Full Text] [Related]  

  • 9. The hemodynamic rationale of propranolol and nitroglycerin in the management of angina pectoris.
    Wiener L
    Med Times; 1970 Jun; 98(6):129-35. PubMed ID: 4986540
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hemodynamic action of effective doses of sustak in patients with stenocardia of effort].
    Volkov NF; Snezhitskiĭ VA; Boreĭsho DE; Rakov AV; Kureĭsha AK; Gushcha IM
    Ter Arkh; 1990; 62(9):41-3. PubMed ID: 2126397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in management of angina pectoris (author's transl)].
    Szczeklik E
    Przegl Lek; 1975; 32(7):603-7. PubMed ID: 240192
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation].
    Mikunis RI; Monastyrskiĭ IuI; Zhebel' VN; Serkova VK; Bogach NT
    Kardiologiia; 1987 Mar; 27(3):99-101. PubMed ID: 3108565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sustak pharmacodynamics in effort stenocardia].
    Nazarenko VA; Nikolenko SA; Martsevich SIu; Savvateev KL; Vygodin VA
    Kardiologiia; 1982; 22(7):57-62. PubMed ID: 6810013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiologic assessment of the hemodynamic effects of sustained release nitroglycerin in patients with angina pectoris.
    Thompson EJ; Glass P; Torres C; Arora J; Piccone VA
    Angiology; 1973 Sep; 24(8):508-14. PubMed ID: 4199545
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action.
    DePace NL; Herling IM; Kotler MN; Hakki AH; Spielman SR; Segal BL
    Arch Intern Med; 1982 Oct; 142(10):1806-9. PubMed ID: 6812520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-anginal and hemodynamic effects of single doses of propranolol, verapamil and nitroglycerin-depot in patients with stenocardia].
    Manak NA; Prokopchuk VP; Laziuk DG
    Kardiologiia; 1988 Mar; 28(3):57-60. PubMed ID: 3132571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ergometric study of the duration of action of a delayed-action trinitrine in angina pectoris patients].
    Biour M; Yvenou L; Khireddine M; Gluck C; Parier JL; Cheymol G
    Therapie; 1988; 43(1):45-9. PubMed ID: 3128886
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of intravenous administration of nitroglycerin on the indicators of central hemodynamics in patients with acute myocardial infarction].
    Afonskaia NI; Ostrogorskiĭ IuM; Karpov IuA; Ivanishvili LO; Iasinovskiĭ VD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):49-54. PubMed ID: 6416267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of high-dose intravenous nitroglycerin on cardiovascular hemodynamic features and left ventricular function at rest and during exercise in patients with exertional angina.
    Harris PJ; Roubin GS; Sadick NN; Choong CY; Bautovich G; Kelly DT
    Am J Cardiol; 1983 Jul; 52(2):113A-118A. PubMed ID: 6408919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.